SIGA - SIGA Technologies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
4.39
+0.20 (+4.77%)
At close: 3:47PM EDT
Stock chart is not supported by your current browser
Previous Close4.19
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume47,603
Market Cap346.41M
Beta1.48
PE Ratio (TTM)-8.52
EPS (TTM)-0.51
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.00
Trade prices are not sourced from all markets
  • GlobeNewswirelast month

    SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on September 27, 2017

    NEW YORK, Sept. 20, 2017-- SIGA Technologies, Inc., a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, today announced that Dr. ...

  • SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
    Capital Cube2 months ago

    SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017

    Categories: Yahoo FinanceGet free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc. and Newlink Genetics Corporation (ACHN-US, ... Read more (Read more...)

  • SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017
    Capital Cube4 months ago

    SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017

    Categories: Yahoo FinanceGet free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc. and Newlink Genetics Corporation (ACHN-US, ... Read more (Read more...)

  • SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
    Capital Cube7 months ago

    SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017

    Categories: Yahoo Finance Get free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc., Newlink Genetics Corporation and NanoViricides, ... Read more (Read more...)

  • SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
    Capital Cube7 months ago

    SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017

    Categories: Yahoo Finance Get free summary analysis SIGA Technologies, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc., Newlink Genetics Corporation and NanoViricides, ... Read more (Read more...)

  • TheStreet.com11 months ago

    PharmAthene Declares Special Cash Dividend

    The biodefense company on Thursday declared a special one-time cash dividend, a day after receiving final payment from Siga in connection with a drug license dispute.

  • Business Wire11 months ago

    SIGA Announces Successful Completion of Rights Offering; Funding of Loan; Completion of Payment of PharmAthene Obligation

    SIGA Technologies, Inc.  today announced the successful completion of its previously announced rights offering , pursuant to which it raised approximately $35.3 million through the sale of 23,523,195 shares of its common stock.

  • SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016
    Capital Cube11 months ago

    SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016

    Categories: Yahoo Finance Get free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Sarepta Therapeutics, Inc., BioCryst Pharmaceuticals, Inc. and Newlink Genetics Corporation (SRPT-US, BCRX-US and NLNK-US) that have also reported for this period. Highlights Summary numbers: ... Read more (Read more...)